[Glucose renal excretion as diabetes treatment: From an old diagnostic method to a new way of treatment]

Med Clin (Barc). 2016 May 20;146(10):460-4. doi: 10.1016/j.medcli.2015.12.003. Epub 2016 Jan 26.
[Article in Spanish]
No abstract available

MeSH terms

  • Benzhydryl Compounds / pharmacology
  • Benzhydryl Compounds / therapeutic use
  • Biomarkers / urine
  • Canagliflozin / pharmacology
  • Canagliflozin / therapeutic use
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / urine
  • Glucosides / pharmacology
  • Glucosides / therapeutic use
  • Glycosuria / chemically induced*
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Renal Elimination / drug effects*
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Benzhydryl Compounds
  • Biomarkers
  • Glucosides
  • Hypoglycemic Agents
  • SLC5A2 protein, human
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors
  • Canagliflozin
  • dapagliflozin
  • empagliflozin